The Kentucky Department for Public Health HIV/AIDS Section assesses the current and future impact of HIV in Kentucky. The section is composed of surveillance, prevention, and services programs. The HIV/AIDS Section is committed to:
- Ensuring that HIV/AIDS surveillance is a quality, secure system;
- Ensuring that all people at risk for HIV infection know their sero-status;
- Ensuring that persons not infected with HIV remain uninfected;
- Ensuring that persons infected with HIV do not transmit HIV to others;
- Ensuring that persons infected with HIV have access to the most effective therapies possible;
- Ensuring a quality professional education program includes the most current HIV/AIDS information.
Find an HIV Test Site
Every county health department in Kentucky and many community based organizations offer free anonymous or confidential HIV tests.
Find a test site near you (opens a new browser window).
Syringe Exchange Programs
To combat growing concern over HIV and Hepatitis C outbreaks, Kentucky law allows county health departments to provide syringe exchange programs. These programs have proven effective in reducing the spread of infections without increasing drug use.
Data to Care
Data to Care (DTC or D2C) is a public health strategy that uses HIV surveillance data to identify People Living with HIV (PLWH) who are not in care and link to re-engage them in care. DTC also supports PLWH along the HIV care continuum. DTC is promoted by the Centers for Disease Control and Prevention (CDC) and implemented by a number of health departments across the US.
Pre-exposure prophylaxis (or PrEP) is a way for people who do not have HIV but who are at very high risk of getting HIV to prevent HIV infection by taking a pill every day. The pill (brand name Truvada) contains two medicines (tenofovir and emtricitabine) that are used in combination with other medicines to treat HIV. When someone is exposed to HIV through sex or injection drug use, these medicines can work to keep the virus from establishing a permanent infection.
People with HIV should take medicine to treat HIV as soon as possible. HIV medicine is called antiretroviral therapy, or ART. If taken as prescribed, HIV medicine reduces the amount of HIV in the body (viral load) to a very low level, which keeps the immune system working and prevents illness. This is called viral suppression—defined as having less than 200 copies of HIV per milliliter of blood. HIV medicine can even make the viral load so low that a test can’t detect it. This is called an undetectable viral load.
HIV/AIDS Continuing Education
This program is responsible for providing training on HIV testing and counseling and on linkage-to-care for those testing positive.
CHFS-sponsored HIV/AIDS Course on TRAIN for all Health Care Personnel (free CME).
Kentucky HIV/AIDS Planning and Advisory Council
Kentucky HIV/AIDS Planning and Advisory Council (KHPAC) is responsible for planning priority interventions for target populations across the state, advising the Cabinet for Health and Family Services regarding HIV/AIDS activity in the commonwealth and providing guidance to the Title II Services Program. Much effort is made to assure the membership of KHPAC reflects the epidemic in our state with representation from all targeted populations.
HIV/AIDS Legislation and Regulations
HIV/AIDS Resources page.
Ending the HIV Epidemic
During the 2019 State of the Union address, the Trump administration announced the new “Ending the HIV Epidemic: A Plan for America.” This will be a ten year initiative beginning in FY 2020 to achieve the important goal of reducing new HIV infections to less than 3,000 per year by 2030. Reducing new infections to this level would essentially mean that HIV transmissions would be rare and meet the definition of ending the epidemic. The initiative will focus efforts in 48 counties, Washington, DC, San Juan (PR), and seven states with substantial rural HIV burden.
HIV/AIDS and African Americans
In the US, the HIV/AIDS epidemic is a health crisis for blacks/African Americans. At all stages of HIV/AIDS - from HIV infection to death with AIDS - blacks/African Americans are disproportionately affected: accounting for a higher proportion of new HIV diagnoses and people living with HIV, compared to other races/ethnicities. In 2017, blacks/African Americans accounted for 13% of the US population, but 43% of new HIV diagnoses in the US and dependent areas. See the fact sheet HIV and African Americans
Ryan White and State-Funded Programs
Please visit our HIV/AIDS Services Program page for additional information about:
Kentucky HIV Care Coordinator Program (KHCCP)
(Continuation of all programs is contingent upon state and federal funding.)
Kentucky AIDS Drug Assistance Program (KADAP)
This program assists low-income, eligible Kentuckians with the purchase of AIDS-related medications prescribed for FDA-approved indications. Once approved, eligible applicants receive formulary medications through a mail-order pharmacy service provided by the
Kentucky Clinic Pharmacy in Lexington. For complete information, call
(866) 510-0005 (toll free).
Kentucky Health Insurance Continuation Program (KHICP)
Provides payments for the continuation of health insurance benefits for eligible individuals who are at risk of losing their employment-related or private-pay health insurance because of HIV disease.
Kentucky Outpatient Health Care and Support Services programs
Provide assistance for eligible individuals with a wide range of community-based medical and non-medical support services, such as, physical and mental health care, housing, nutrition and transportation services. From the list of eligible services, priority services are identified during each funding period, based on such factors as client and care coordinator input, needs assessment survey results, resource inventories, client satisfaction surveys and funding limitations.
For additional information, please visit our HIV/AIDS Services Program page.